Patron members

The new Patron category, in addition to all AmCham benefits, entitles you also to:
  • five free of charge participations at AmCham events within a year (except for charity gala dinners such as the Evening for safe steps)
  • logo displayed at all events and in all AmCham publications
  • logo displayed on AmCham website with a link to your website
  • special events for Patrons only
  • Q bulletin free ads – additional 3 ads compared to other members
  • 20% discount on all advertising
  • 1 free E-bulletin ad
If you would like to upgrade your membership to Patron category or need any additional info, please contact AmCham office.
    • Abbott Laboratories d.o.o.
    • AbbVie d.o.o.
    • Addiko Bank d.d.
    • Atlantic grupa d.d.
    • Coca-Cola Adria d.o.o.
    • Cisco Systems Hrvatska d.o.o.
    • DOK-ING d.o.o.
    • Ernst & Young d.o.o.
    • Hewlett-Packard d.o.o. - Hewlett Packard Enterprise
    • Erste Card Club d.o.o.
    • Gavrilović d.o.o.
    • Zagreb City Hotels d.o.o. (DoubleTree by Hilton Zagreb)
    • Hrvatska banka za obnovu i razvitak
    • Hrvatski Telekom d.d.
    • HS Produkt d.o.o.
    • IBM Hrvatska d.o.o.
    • Johnson & Johnson S.E. d.o.o.
    • JT International Zagreb d.o.o.
    • McKinsey & Company, Inc. Croatia
    • Merck Sharp & Dohme d.o.o.
    • Microsoft Hrvatska d.o.o.
    • NOVA TV d.d.
    • Novartis Hrvatska d.o.o.
    • Offline Solutions d.o.o.
    • Oracle Hrvatska d.o.o.
    • Orbico d.o.o.
    • PBZ Card d.o.o.
    • Philip Morris Zagreb d.o.o.
    • Pliva Hrvatska d.o.o.
    • Podravka d.d.
    • Poliklinika Bagatin
    • PricewaterhouseCoopers d.o.o. (PwC Croatia)
    • Roche d.o.o.
    • SELECTIO Kadrovi d.o.o.
    • Teknoxgroup Hrvatska d.o.o.
    • Uber Croatia d.o.o.
    • Willis Towers Watson d.d.
    • Zagrebačka škola ekonomije i managementa
    • SHIRE d.o.o.
      • Website:http://www.shire.com
      •  
      • Description:

        Newly combined with Baxalta, Shire is now the leading global biotechnology company focused on serving people affected by rare diseases and highly specialized conditions. These diseases are often misunderstood, under-diagnosed, and potentially life-threatening. Our 22,000 employees come to work every day with a common purpose: to develop and deliver breakthrough therapies that enable people with life-altering conditions to live their lives to the fullest. At Shire, we are dedicated to expanding, building and sustaining leadership across our key therapeutic areas through our extensive portfolio of products, innovative pipeline and collaborative approach to working with diverse partners around the globe. We strive to earn and keep the trust of our patients, their families and physicians, and all others who support and advance their care. Working together, the possibilities for our patients, healthcare partners and employees are unprecedented, with significant growth potential for our shareholders.